High Tide Reports Record Revenue & Adjusted EBITDA for FY2025, Achieves FCF Positive Goal Despite Non-Cash Net Loss
HITI sits 48% above its 52-week low of $1.64.
Summary
High Tide Inc. reported record revenue and Adjusted EBITDA for Q4 and fiscal year 2025, achieving its free cash flow positive goal, while also disclosing a significant non-cash net loss primarily due to impairment charges.
Key Events · Earnings and Guidance · HITI
-
Record Revenue
Q4 2025 revenue reached a record $164.0 million, up 19% year-over-year, with full fiscal year 2025 revenue at $593.986 million.
-
Record Adjusted EBITDA
Adjusted EBITDA hit a record $12.4 million in Q4 2025, a 51% increase year-over-year, contributing to $38.208 million for the full fiscal year.
-
Free Cash Flow Positive
The company generated $12.0 million in free cash flow for fiscal year 2025, successfully meeting its stated goal of remaining FCF positive.
-
Significant Net Loss
High Tide reported a net loss of $46.7 million in Q4 2025 and $51.404 million for the full fiscal year, primarily due to non-cash impairment charges and fair value changes in derivative liabilities.
Analysis · HITI · Trade & Services
This 6-K provides a comprehensive overview of High Tide's Q4 and fiscal year 2025 performance, following the 40-F filing on the same day. The company demonstrated strong operational growth with record revenue and Adjusted EBITDA, successfully expanding its retail footprint and loyalty programs. A key achievement was remaining free cash flow positive for the fiscal year, indicating improved financial discipline. However, the substantial GAAP net loss, driven by non-cash impairment of its e-commerce segment and derivative liability adjustments, will require investor scrutiny. The report also highlights strategic progress in the German medical cannabis market and potential opportunities in the U.S. CBD sector, signaling future growth avenues.
At the time of this filing, HITI was trading at $2.42 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $211.7M. The 52-week trading range was $1.64 to $4.06. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.